In this commentary I discuss the recent study that made headlines concerning possible long-term risks from using ADHD medications. I then discuss a more thorough review and meta-analysis of these risks that found no signals of long-term cardiac risks from ADHD medication use. These two studies are:

Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines
A Holt, JE Strange, PV Rasmussen, N Nouhravesh… - European Heart Journal, 2023
[ Ссылка ]

Zhang, L et al. (2022). Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity DisorderA Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(11):e2243597. doi:10.1001/jamanetworkopen.2022.43597

свернуть